Article in JCO global oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
6 authors.
Parth SharmaParth Sharma, MBBS, Association for Socially Applicable Research (ASAR), Pune, India, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India; Muttacaud Ramakrishnan Rajagopal, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; Enrique Soto-Perez-de-Celis, MD, PhD, FASCO, Departamento de Geriatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Charmaine Blanchard, MBBCh, MPhil, PD Dip Pall Med, Centre for Palliative Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Deepak Sudhakaran, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; and Aju Mathew, MD, DM, MBBS, MPhil, MOSC Medical College, Kolenchery, India.ORCID 0000-0003-4954-6031
Muttacaud Ramakrishnan RajagopalParth Sharma, MBBS, Association for Socially Applicable Research (ASAR), Pune, India, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India; Muttacaud Ramakrishnan Rajagopal, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; Enrique Soto-Perez-de-Celis, MD, PhD, FASCO, Departamento de Geriatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Charmaine Blanchard, MBBCh, MPhil, PD Dip Pall Med, Centre for Palliative Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Deepak Sudhakaran, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; and Aju Mathew, MD, DM, MBBS, MPhil, MOSC Medical College, Kolenchery, India.ORCID 0000-0003-3760-2796
Enrique Soto-Perez-de-CelisParth Sharma, MBBS, Association for Socially Applicable Research (ASAR), Pune, India, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India; Muttacaud Ramakrishnan Rajagopal, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; Enrique Soto-Perez-de-Celis, MD, PhD, FASCO, Departamento de Geriatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Charmaine Blanchard, MBBCh, MPhil, PD Dip Pall Med, Centre for Palliative Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Deepak Sudhakaran, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; and Aju Mathew, MD, DM, MBBS, MPhil, MOSC Medical College, Kolenchery, India.ORCID 0000-0002-7301-2163
Charmaine BlanchardParth Sharma, MBBS, Association for Socially Applicable Research (ASAR), Pune, India, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India; Muttacaud Ramakrishnan Rajagopal, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; Enrique Soto-Perez-de-Celis, MD, PhD, FASCO, Departamento de Geriatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Charmaine Blanchard, MBBCh, MPhil, PD Dip Pall Med, Centre for Palliative Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Deepak Sudhakaran, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; and Aju Mathew, MD, DM, MBBS, MPhil, MOSC Medical College, Kolenchery, India.ORCID 0000-0002-9302-1454
Deepak SudhakaranParth Sharma, MBBS, Association for Socially Applicable Research (ASAR), Pune, India, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India; Muttacaud Ramakrishnan Rajagopal, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; Enrique Soto-Perez-de-Celis, MD, PhD, FASCO, Departamento de Geriatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Charmaine Blanchard, MBBCh, MPhil, PD Dip Pall Med, Centre for Palliative Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Deepak Sudhakaran, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; and Aju Mathew, MD, DM, MBBS, MPhil, MOSC Medical College, Kolenchery, India.ORCID 0000-0002-1712-1904
Aju MathewParth Sharma, MBBS, Association for Socially Applicable Research (ASAR), Pune, India, Department of Community Medicine, Maulana Azad Medical College, New Delhi, India; Muttacaud Ramakrishnan Rajagopal, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; Enrique Soto-Perez-de-Celis, MD, PhD, FASCO, Departamento de Geriatría, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; Charmaine Blanchard, MBBCh, MPhil, PD Dip Pall Med, Centre for Palliative Care, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, Strengthening Oncology Services Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Deepak Sudhakaran, MD, MBBS, Trivandrum Institute of Palliative Sciences, Trivandrum, India; and Aju Mathew, MD, DM, MBBS, MPhil, MOSC Medical College, Kolenchery, India.ORCID 0000-0002-5482-5708
Funding
Novel predictors of survival among breast cancer patients with/without HIV in South AfricaR01CA250012 · NCI · WITS HEALTH CONSORTIUM (PTY), LTD · PI CUBASCH, HERBERT, EL-SADR, WAFAA M. · 2020 to 2024
$2.0M
NCI NIH HHS R01 CA250012
6 · The paper itself
Abstract
It is relevant to study the financial toxicity of cancer to address it. However, the existing tools fail to capture the financial destruction of cancer on patients and their families in resource-limited countries. The authors discuss the need for a new tool in this article.
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Local Sociocultural Practice Specific Financial Toxicity Assessment Tool for Cancer: An Emerging Need. · full record | OpenQuestion